Genpact (G) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Genpact (NYSE:G) posted its quarterly earnings data on Monday. The business services provider reported $0.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.02, Bloomberg Earnings reports. Genpact had a return on equity of 23.86% and a net margin of 10.18%. The firm had revenue of $734.41 million during the quarter, compared to analyst estimates of $723.55 million. During the same period last year, the company posted $0.43 EPS. The business’s quarterly revenue was up 7.7% on a year-over-year basis. Genpact updated its FY18 guidance to $1.70-1.74 EPS.

Shares of Genpact (NYSE G) opened at $32.30 on Tuesday. Genpact has a 12-month low of $23.34 and a 12-month high of $34.79. The company has a market capitalization of $6,240.00, a PE ratio of 23.41, a P/E/G ratio of 1.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.65 and a quick ratio of 1.65.

In related news, insider Private Ltd Gic sold 1,499,806 shares of the business’s stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $30.26, for a total value of $45,384,129.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $33.95, for a total value of $770,325.50. The disclosure for this sale can be found here. Insiders sold a total of 1,660,470 shares of company stock valued at $50,598,982 over the last ninety days. 1.41% of the stock is currently owned by corporate insiders.

An institutional investor recently raised its position in Genpact stock. The Manufacturers Life Insurance Company raised its stake in shares of Genpact Limited (NYSE:G) by 7.5% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 6,508 shares of the business services provider’s stock after purchasing an additional 455 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 as of its most recent SEC filing. 92.00% of the stock is currently owned by institutional investors.

G has been the subject of several research analyst reports. Cantor Fitzgerald reissued a “buy” rating and issued a $36.00 price objective on shares of Genpact in a research report on Wednesday, November 8th. Zacks Investment Research raised Genpact from a “sell” rating to a “hold” rating and set a $35.00 price objective for the company in a research report on Friday, November 10th. Finally, Robert W. Baird reissued a “buy” rating and issued a $38.00 price objective on shares of Genpact in a research report on Friday, November 10th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $33.38.

ILLEGAL ACTIVITY WARNING: “Genpact (G) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/12/genpact-g-issues-earnings-results-beats-expectations-by-0-01-eps.html.

Genpact Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Earnings History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply